Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
585.39B
Market cap585.39B
Price-Earnings ratio
22.03
Price-Earnings ratio22.03
Dividend yield
2.14%
Dividend yield2.14%
Average volume
8.08M
Average volume8.08M
High today
$247.20
High today$247.20
Low today
$241.87
Low today$241.87
Open price
$244.81
Open price$244.81
Volume
6.86M
Volume6.86M
52 Week high
$251.71
52 Week high$251.71
52 Week low
$141.50
52 Week low$141.50

Stock Snapshot

With a market cap of 585.39B, Johnson & Johnson(JNJ) trades at $244.10. The stock has a price-to-earnings ratio of 22.03 and currently yields dividends of 2.1%.

On 2026-04-04, Johnson & Johnson(JNJ) stock traded between a low of $241.87 and a high of $247.20. Shares are currently priced at $244.10, which is +0.9% above the low and -1.3% below the high.

Johnson & Johnson(JNJ) shares are trading with a volume of 6.86M, against a daily average of 8.08M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $251.71 and a 52-week low of $141.50.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $251.71 and a 52-week low of $141.50.

JNJ News

Nasdaq 9h
Better Healthcare Stock to Own in a Recession: Defensive or Growth?

Key Points Defensive healthcare stocks such as Johnson & Johnson and CVS tend to outperform in recessions. Growth healthcare stocks offer higher risk and pote...

Better Healthcare Stock to Own in a Recession: Defensive or Growth?
Simply Wall St 19h
Johnson And Johnson Expands Sirturo Reach In Japan With KYORIN Deal

Johnson & Johnson (NYSE: JNJ) has agreed to an exclusive distribution and promotion deal with KYORIN Pharmaceutical for SIRTURO (Bedaquiline) in Japan. The com...

Johnson And Johnson Expands Sirturo Reach In Japan With KYORIN Deal
24/7 Wall St. 1d
The S&P 500 Without Big Tech Is Quietly Beating the Full Index in 2026

The S&P 500 Without Big Tech Is Quietly Beating the Full Index in 2026 By John Seetoo Published Apr 3, 9:18AM EDT Quick Read Defiance Large Cap ex-Mag 7 (XMAG...

The S&P 500 Without Big Tech Is Quietly Beating the Full Index in 2026

Analyst ratings

59%

of 29 ratings
Buy
58.6%
Hold
34.5%
Sell
6.9%

More JNJ News

24/7 Wall St. 2d
The 5 Safest Dividend Aristocrats Are Perfect For Retirees Needing Growth & Income

The 5 Safest Dividend Aristocrats Are Perfect For Retirees Needing Growth & Income By Lee Jackson Published Apr 2, 8:10AM EDT Quick Read The Dividend Aristocr...

The 5 Safest Dividend Aristocrats Are Perfect For Retirees Needing Growth & Income
The Motley Fool 2d
This Healthcare Stock Barely Flinches During Market Sell-Offs

Johnson & Johnson (JNJ 0.09%), since its 2023 spinoff of its consumer health division into Kenvue (KVUE +0.81%), no longer sells bandages. However, if you're lo...

This Healthcare Stock Barely Flinches During Market Sell-Offs
The Motley Fool 3d
Stagflation Fears Are Back: These 3 Stocks Can Help You Ride Out the Storm

Searches for the phrase "stagflation 2026" have skyrocketed more than 650% over the last three months, according to Google Trends. It's easy to understand why....

Stagflation Fears Are Back: These 3 Stocks Can Help You Ride Out the Storm
The Motley Fool 3d
Legend Biotech Q2 2025 Earnings Transcript

Image source: The Motley Fool. Monday, Aug. 11, 2025 at 8 a.m. ET Call participants Chief Executive Officer — Ying Huang President of CARVYKTI — Alan S. Bash...

Legend Biotech Q2 2025 Earnings Transcript
Nasdaq 3d
JNJ Crosses Above Average Analyst Target

In recent trading, shares of Johnson & Johnson (Symbol: JNJ) have crossed above the average analyst 12-month target price of $180.54, changing hands for $181.62...

JNJ Crosses Above Average Analyst Target
Nasdaq 4d
Volatility Is Spiking. Here Are 3 Dividend Stocks You Can Buy Without Hesitation.

Key Points Johnson & Johnson has a stronger credit rating than the U.S. government. PepsiCo's brand loyalty gives it considerable pricing power. Walmart rank...

Volatility Is Spiking. Here Are 3 Dividend Stocks You Can Buy Without Hesitation.
Nasdaq 4d
The Dividend King That's Raised Its Payout for 63 Consecutive Years

Key Points Johnson & Johnson is a Dividend King. The company's strong operations suggest regular payout increases aren't a thing of the past. 10 stocks we li...

The Dividend King That's Raised Its Payout for 63 Consecutive Years

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.